LMO2 confers synthetic lethality to PARP inhibition in DLBCL

Deficiency in DNA double-strand break (DSB) repair mechanisms has been widely exploited for the treatment of different malignances, including homologous recombination (HR)-deficient breast and ovarian cancers. Here we demonstrate that diffuse large B cell lymphomas (DLBCL) expressing LMO2 protein ar...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Cell
Main Authors: Parvin, Salma, Ramirez-Labrada, Ariel, Aumann, Shlomzion, Lu, XiaoQing, Weich, Natalia, Santiago, Gabriel, Cortizas, Elena M., Sharabi, Eden, Zhang, Yu, Sanchez-Garcia, Isidro, Gentles, Andrew J., Roberts, Evan, Cortes, Daniel Bilbao, Vega, Francisco, Chapman, Jennifer R., Verdun, Ramiro E., Lossos, Izidore S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6752209/
https://ncbi.nlm.nih.gov/pubmed/31447348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2019.07.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados